ARTV
ARTV
US04317A1079
Artiva Biotherapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- 251.000
--
Cost of Revenue -- --
--
Gross Profit -- --
--
89.810.000 67.533.000
33.0%
Operating Income -89.810.000 -67.282.000
33.5%
Pretax Income -83.865.000 -58.179.000
44.1%
Net Income Common Stockholders -83.865.000 -58.179.000
44.1%
-- --
--
-- --
--
ende